Publicaciones en las que colabora con Alma Viso Beronda (17)

2017

  1. Development of a Nucleotide Exchange Inhibitor That Impairs Ras Oncogenic Signaling

    Chemistry - A European Journal, Vol. 23, Núm. 7, pp. 1676-1685

2011

  1. Development of non-peptide ligands of growth factor receptor-bound protein 2-src homology 2 domain using molecular modeling and NMR spectroscopy

    Journal of Medicinal Chemistry, Vol. 54, Núm. 4, pp. 1096-1100

2010

  1. Development of fluorescent ligands for the human 5-HT1A receptor

    ACS Medicinal Chemistry Letters, Vol. 1, Núm. 6, pp. 249-253

  2. Development of molecular probes for the human 5-HT6 receptor

    Journal of Medicinal Chemistry, Vol. 53, Núm. 19, pp. 7095-7106

2008

  1. The medicinal chemistry of agents targeting monoacylglycerol lipase

    Current Topics in Medicinal Chemistry, Vol. 8, Núm. 3, pp. 231-246

2005

  1. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

    FASEB Journal, Vol. 19, Núm. 10, pp. 1338-1340

  2. Involvement of cannabinoids in cellular proliferation

    Mini-Reviews in Medicinal Chemistry

2004

  1. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: Synthesis of new transporter inhibitors as tools for this study

    British Journal of Pharmacology, Vol. 141, Núm. 3, pp. 457-467

  2. Comparison of anandamide transport in FAAH wild-type and knockout neurons: Evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake

    Biochemistry, Vol. 43, Núm. 25, pp. 8184-8190

2003

  1. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors

    European Journal of Medicinal Chemistry

  2. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: Comparison with effects on fatty acid amidohydrolase

    Journal of Medicinal Chemistry, Vol. 46, Núm. 8, pp. 1512-1522

  3. Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 18, Núm. 3, pp. 225-231

  4. VR1 receptor modulators as potential drugs for neuropathic pain.

    Mini reviews in medicinal chemistry, Vol. 3, Núm. 7, pp. 729-748

2002

  1. Endocannabinoid transporter inhibitors

    Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Núm. 2, pp. 129-141

  2. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide

    European Journal of Pharmacology, Vol. 449, Núm. 1-2, pp. 99-103

2001

  1. Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors

    Journal of Medicinal Chemistry, Vol. 44, Núm. 26, pp. 4505-4508

  2. Nuevas tendencias en la utilidad terapeútica de los cannabinoides

    Anales de Química de la RSEQ, Núm. 2, pp. 14-21